寒喘祖帕颗粒联合常规西药治疗儿童支气管哮喘临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6

基金项目:


Clinical Study on Hanchuan Zupa Granules Combined with Routine Western Medicine for Bronchial Asthma in Children
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察寒喘祖帕颗粒联合常规西药治疗儿童支气管哮喘的临床疗效。方法:选择风寒痰湿型支气管哮喘患儿98 例,按随机数字表法分为观察组 50 例和对照组 48 例。2 组患儿入院后均接受常规基础治疗,对照组给予万托林雾化吸入治疗,观察组在对照组基础上加用寒喘祖帕颗粒治疗,连续治疗 7 d。比较 2 组临床疗效、症状消失时间、血清炎症因子水平及肺功能指标改善情况。结果:观察组总有效率为 86.00%,对照组为 66.67%,2 组比较,差异有统计学意义 (P<0.05)。观察组咳嗽消失时间、喘息消失时间、哮鸣音消失时间及呼吸困难消失时间均短于对照组 (P<0.05)。治疗前,2 组白细胞介素-4 (IL-4)、肿瘤坏死因子-α(TNF-α)水平比较,差异无统计学意义(P>0.05)。治疗后,2 组 IL-4、TNF-α 水平较治疗前下降,且观察组 IL-4、TNF-α 水平低于对照组,差异均有统计学意义 (P<0.05)。治疗前,2 组肺功能指标比较,差异无统计学意义(P>0.05)。治疗后,2 组用力肺活量 (FVC)、最大呼气流速 (PEF) 及用力呼气量占用力肺活量比值 (FEV1/FVC) 较治疗前明显上升(P<0.05),观察组 FVC、PEF、FEV1/FVC 上升幅度明显大于对照组(P<0.05)。结论:寒喘祖帕颗粒联合西药治疗风寒痰湿型支气管哮喘患儿临床疗效显著,可有效促进患儿症状缓解,抑制呼吸道炎症反应,改善肺功能。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Hanchuan Zupa granules combined with routine western medicine for bronchial asthma in children. Methods:A total of 98 cases of children with bronchial asthma of wind-cold and phlegmdampness type were selected and divided into the observation group and the control group according to the random number table method, 50 and 48 cases in each group respectively. After admission, both groups were given routine basic treatment;the control group was given ventolin aerosol inhalation,and the observation group was additionally treated with Hanchuan Zupa granules based on the treatment of the control group. Both groups were treated for seven days. The clinical effect,disappearance time of symptoms as well as the improvement of levels of serum inflammatory factors and indexes of lung function in the two groups were compared. Results:The total effective rate was 86.00% in the observation group and 66.67% in the control group, the difference being significant(P<0.05). The disappearance time of coughing, wheezing, wheezing rales and dyspnea in the observation group was shorter than that in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of the levels of interleukin- 4(IL-4) and tumor necrosis factor-α(TNF-α) between the two groups(P>0.05). After treatment,the levels of IL-4 and TNF-α in the two groups were decreased when compared with those before treatment,and the levels in the observation group were lower than those in the control group,differences being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of lung function indexes between the two groups(P>0.05). After treatment,the forced vital capacity(FVC), the peak expiratory flow rate(PEF) and the ratio of forced expiratory volume in one second to forced vital capacity(FEV1/FVC) in the two groups were significantly increased when compared with those before treatment(P<0.05),and the increase in the observation group was significantly higher than that in the control group(P<0.05). Conclusion:The therapy of Hanchuan Zupa granules combined with western medicine has significant clinical effect in treating children with bronchial asthma of wind-cold and phlegm- dampness type, which can effectively promote the remission of symptoms, inhibit the respiratory tract inflammation and improve the lung function.

    参考文献
    相似文献
    引证文献
引用本文

周静.寒喘祖帕颗粒联合常规西药治疗儿童支气管哮喘临床研究[J].新中医,2021,53(7):93-96

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-04-08
  • 出版日期:
文章二维码